The modified carbapenem inactivation method (mCIM) is a simple phenotypic screening method for detecting carbapenemase production by Enterobacteriaceae and Pseudomonas aeruginosa. We recently developed another modified carbapenem inactivation method (CIMTris), in which carbapenemase is extracted from bacteria with Tris-HCl buffer, to detect carbapenemase production by Acinetobacter and Pseudomonas species. This study describes an improved carbapenem inactivation method, CIMTrisII, for detecting carbapenemase production by Gram-negative pathogens, including Enterobacteriaceae, Acinetobacter and Pseudomonas species. CIMTrisII was different from CIMTris in the concentration of Meropenem disks (5-µg MEM disks vs. 10-µg MEM disks), the inoculum volume of the bacteria (a 5-µl loopful vs. a 10 µl loopful) and the incubation time (1 vs. 2 h). CIMTrisII showed an overall sensitivity of 99.3 % and an overall specificity of 95.0 % for tested isolates. In comparison, CIMTris showed a sensitivity of 96.1 % and a specificity of 96.3 %, and mCIM showed a sensitivity of 67.1 % and a specificity of 100 %. CIMTrisII is thus deemed useful for detecting carbapenemase production by Gram-negative pathogens.
INTRODUCTION
The emergence and spread of carbapenem-resistant Gramnegative pathogens, including Enterobacteriaceae and Acinetobacter and Pseudomonas species, have become serious problems in medical settings worldwide [1] [2] [3] . Many carbapenem-resistant pathogens produce acquired carbapenemases, including KPC-type b-lactamases, and metallo-blactamases, such as DIM-, KHM-, IMP-, NDM-and VIMtype enzymes [4] . In addition, some variants of OXA-type b-lactamases, such as OXA-23, -48, À58 and À72, and extended-spectrum b-lactamases, such as GES-5 and À6, have shown carbapenemase activity [4] .
The carbapenem inactivation method (CIM) was originally developed to detect carbapenemase activity in Gram-negative pathogens [5] . This method was shown to be a useful tool in microbiology laboratories because of its simplicity, widespread availability and lower costs than the RAPIDEC CARBA NP test (bioMeriux, France), a commercially available modified version of the Carba NP test, as well as the Carba NP test and modified Hodge test [6, 7] . To increase the sensitivity of the original CIM, the modified CIM (mCIM) was developed for detection of carbapenemase production by Enterobacteriaceae [8] . The mCIM method is more sensitive than CIM in detecting carbapenemase production by both Enterobacteriaceae and glucose-non-fermenting Gram-negative bacilli [9, 10] . The Clinical and Laboratory Standards Institute (CLSI) now recommends the mCIM for detection of carbapenemase production by Enterobacteriaceae and Pseudomonas species (CLSI M100-S28). The mCIM was further modified using a nephelometer [11] or with pre-incubation of the susceptible E. coli reference strain [12] on the plate for rapid detection of carbapenemase production. Another modification of the mCIM used Triton X-100 and a greater volume of Acinetobacter baumannii as test bacteria [13] . could detect carbapenemase production by Acinetobacter and Pseudomonas species [14] . However, CIMTris shows relatively low sensitivity in detecting carbapenemase production by Enterobacteriaceae [14] . To address this issue we developed CIMTrisII, which requires an incubation time of only 1 h and uses a 5-µg rather than a 10-µg Meropenem (MEM) disk as carbapenemase substrate. This study also describes the ability of the CIMTrisII to detect carbapenemase production by Enterobacteriaceae and Acinetobacter and Pseudomonas species.
METHODS

Bacterial strains
The selected isolates of Gram-negative bacteria producing a variety of carbapenemases were readily available in the three participating laboratories (RU, JU and NHL) Fifty-seven clinical isolates of Acinetobacter species, 75 of Enterobacteriaceae and 95 of Pseudomonas were obtained from hospitalized patients in Japan (142 isolates), Myanmar (35 isolates), Nepal (43 isolates) and Vietnam (seven isolates). Of the 57 Acinetobacter isolates, 28 were from the respiratory tract, 13 from wounds, nine from the urinary tract, four from the gastrointestinal tract, two from blood and one from an unknown source. Of the 75 Enterobacteriaceae isolates, 11 were from the respiratory tract, four from wounds, 26 from the urinary tract, 19 from the gastrointestinal tract, 11 from blood and four from unknown sources. Of the 95 Pseudomonas isolates, 37 were from the urinary tract, 23 from the respiratory tract, 24 from wounds, eight from the gastrointestinal tract, one from blood and two from unknown sources. Controls included Escherichia coli DH5a expressing PER-1, -7 or À8 [15] , Klebsiella pneumoniae ATCC BAA-1705 harbouring bla KPC-2 and À1706 not harbouring any acquired carbapenemase-encoding gene, with E. coli ATCC25922 used as a carbapenem-susceptible reference strain.
Drug susceptibility testing
The minimum inhibitory concentrations (MICs) of imipenem (IPM) and MEM were determined using a microdilution method, as recommended by CLSI guidelines (M07-A9).
DNA sequencing
The entire genome of each isolate was extracted using DNeasy Blood and Tissue kits (QIAGEN, Tokyo, Japan) and sequenced using MiSeq (Illumina, San Diego, CA), with the latter results used to determine bacterial species. The sequences of drug resistance genes available at the National Center for Biotechnology Information (NCBI) website (https://www.ncbi.nlm.nih.gov/pathogens/beta-lactamasedata-resources/), were compared with our sequencing data, and the drug resistance genes were determined using CLC genomics workbench version 9.0.1.
CIMTrisII, CIMTris and mCIM
CIMTrisII was performed by emulsifying a 5-µl loopful (or one-third of a 10 µl loopful) of bacteria in 400 µl of 0.5 M Tris-HCl buffer (pH 7.6) (Kohjin Bio, Japan). Each mixture was vortexed for 10-15s, and a 5 µg MEM disk (CIMTrisII, Kohjin Bio) was added to each tube. The tubes were incubated at 35 C for 1 h, unless otherwise indicated. The MEM disks were removed and placed on Mueller-Hinton II agar plates (Kohjin Bio) inoculated with MEM-susceptible E. coli ATCC25922. The plates were incubated for 18 h at 35 C, and the diameter (mm) of each inhibition zone was measured. Carbapenemase activity was regarded as positive if the inhibition zone measured 6-15 mm, or 16-18 mm with satellite colonies, and as negative if the inhibition zone measured !16 mm or 16-18 mm without satellite colonies. CIMTris was performed as described previously [14] . The only difference between CIMTris and CIMTrisII is the concentration of MEM disk and the bacterial inoculum volume.
The mCIM method to detect carbapenemase activity in Enterobacteriaceae and Pseudomonas species was performed by CLSI M100-S28.
Statistics
Results were compared statistically using chi-squared tests, with P-values <0.05 considered statistically significant.
RESULTS AND DISCUSSION
A 1 h incubation time and one-third of a 10 µl loopful or a 5-µl loopful were optimal in the case of CIMTrisII. To optimize the incubation time of bacterial suspensions with 5 -µg MEM disks in CIMTrisII, the suspensions were incubated with MEM disks at 35 C for 1 and 2 h ( Table 1 ). All isolates harbouring acquired carbapenemase-encoding a, All bacterial isolates used are listed in Table 2 .
b, Acquired carbapenemase-encoding genes are listed in Table 2 .
c, Percentage of isolates tested that were CIMTrisII-positive (34/35). a, Numbers of isolates tested (numbers of isolates harbouring acquired carbapenemase-encoding genes that were positive/numbers of isolates not harbouring these genes).
genes tested, except for an Acinetobacter species isolate, were positive on CIMTrisII when incubated for 1 h, with similar results after incubation for 2 h. Among isolates not harbouring any acquired carbapenemase-encoding genes, 9.1 % of Acinetobacter species isolates, 6.1 % of Enterobacteriaceae isolates and 0 % of Pseudomonas species isolates were false-positive on CIMTrisII when incubated for 1 h. When incubated for 2 h, however, 59.1, 39.4 and 36.0 % of these isolates, respectively, yielded false-positive results.
When incubated for 30 m, all A. baumannii and P. aeruginosa isolates harbouring acquired carbapenemase-encoding genes tested showed weakly positive results after incubation for 30 min (data not shown). The quantity of bacteria tested was set at one-third of a 10 µl loopful or a 5-µl loopful, because these amounts in most of the isolates not harbouring any acquired carbapenemase-encoding genes were negative on CIMTrisII (data not shown). In contrast, testing of 10 µl loopfuls of most of these isolates yielded false-positive results, and testing of 1 µl loopfuls of three isolates of E. coli harbouring bla GES-5 yielded false-negative results on CIMTrisII (data not shown). Emulsification of one-third of a 10 µl loopful of bacteria ( Fig. 1 ) in 400 µl of saline, followed by a tenfold dilution, yielded suspensions with absorbances at 600 nm of 1.5 for Enterobacteriaceae and 0.8 for Pseudomonas species isolates.
The results for CIMTrisII, CIMTris and mCIM are shown in Tables 2, 3 and 4 . CIMTrisII showed 100 % sensitivity and 93.9 % specificity for detecting carbapenemase production by Enterobacteriaceae species isolates (P<0.01) ( Table 2) . Among the 80 Enterobacteriaceae species isolates tested, 47 (58.8 %) harboured acquired genes encoding carbapenemases, including GES-5, IMPtype, KHM-1, KPC-2, NDM-type and OXA-48 (Table 3) , and all 47 isolates were positive on CIMTrisII. Of the remaining 33 isolates not harbouring any acquired carbapenemase-encoding genes, 31 (93.9 %) were negative on CIMTrisII. The remaining two not harbouring any acquired carbapenemase-encoding genes were falsely positive on CIMTrisII.
CIMTris showed 93.6 % sensitivity and 100 % specificity in the detection of carbapenemase production by Enterobacteriaceae species isolates (Table 2) . Three E. coli isolates harbouring the carbapenemase-encoding gene bla GES-5 , were false-negative according to CIMTris. The MIC values with MEM for the three isolates were not high (1-2 µg ml
À1
), suggesting that these isolates probably produced insufficient amounts of carbapenemases (Table 3) , whereas mCIM showed 100 % sensitivity and 100 % specificity (Table 2) .
CIMTrisII showed 97.1 % sensitivity and 90.9 % specificity in the detection of carbapenemase activity in Acinetobacter species (P<0.01) ( Table 2 ). Among 57 Acinetobacter species isolates tested, 32 (56.1 %) harboured acquired genes encoding carbapenemases, including IMP-type, NDM-1 and OXA-type (Table 4 ). In addition, three isolates had intrinsic carbapenemase-encoding genes, OXA-51-like, À69 and À82, with MIC MEM values of 1, 64 and 16 µg ml
, respectively. All three isolates had inserted ISAba1 elements providing promoter sequences upstream of these intrinsic genes [16] . Among these 35 isolates, 34 (97.1 %) were positive according to CIMTrisII. The remaining isolate, Acinetobacter radioresistens harbouring a carbapenemase-encoding gene, bla OXA-23-like , was negative according to CIMTrisII. This isolate was susceptible to MEM, and probably produced insufficient amounts of carbapenemases. Among the 22 isolates not harbouring any acquired carbapenemaseencoding genes, 16 were A. baumannii, which harbours intrinsic carbapenemase-encoding genes [1] . Among these 22 isolates, 20 (90.9 %) were negative according to CIMTrisII whereas the other two, both A. baumannii, were positive despite their lack of an ISAba1 element upstream of their intrinsic carbapenemase genes.
CIMTris showed 91.4 % sensitivity and 95.4 % specificity in the detection of carbapenemase production by Acinetobacter species isolates ( Table 2 ). The mCIM method showed 25.7 % sensitivity and 100 % specificity in the detection of carbapenemase production by Acinetobacter species isolates (Table 2) . Carbapenemase-encoding genes in the nine mCIM-positive isolates included IMP-10 in two, IMP-14 in one, NDM-1 in two and OXA-72 in four (Table 4) . The low sensitivity of mCIM toward Acinetobacter isolates may have been due to their harbouring of acquired genes encoding OXA-type carbapenemases, all of which were negative with mCIM.
CIMTrisII showed 100 % sensitivity and 100 % specificity in the detection of carbapenemase production by Pseudomonas species (P<0.01) ( Table 2 ). Among 95 Pseudomonas species isolates tested, 70 (73.7 %) harboured acquired genes encoding the carbapenemases DIM-1, GES-type, IMP-type, c, Of 12 P. aeruginosa isolates, five harboured a GES-1-encoding gene, one harboured GES-7 and two harboured GES-9, whereas four did not harbour any b-lactamase genes. GES À1, -7 and À9 have no carbapenemase activity.
NDM-1 and VIM-type. All 70 of these isolates were positive on CIMTrisII (Table 4) ; the remaining 25 isolates, which did not harbour any acquired carbapenemase-encoding genes, were negative.
CIMTris showed 100 % sensitivity toward Pseudomonas species isolates and 92.0 % specificity ( Table 2 ). The mCIM method showed 65.7 % sensitivity and 100 % specificity (Table 2) . Among 57 Pseudomonas species isolates tested, 24 harboured carbapenemase-encoding genes but mCIM-negative. Among the 24 mCIM-negative isolates, 21, one and two harbored acquired genes encoding GES-5 and VIM-2, respectively ( Table 4 ), indicating that mCIM was unable to detect GES-type b-lactamases in Pseudomonas species.
Collectively, the CIMTrisII showed 99.3 % sensitivity and 95.0 % specificity ( Table 2 ). In comparison, CIMTris showed 96.1 % sensitivity and 96.3 % specificity while mCIM yielded 67.1 % sensitivity and 100 % specificity. CIMTrisII is therefore capable of detecting carbapenemase production by most Gram-negative pathogens, including OXA-type carbapenemases by Acinetobacter species and GES-type carbapenemases by Pseudomonas species. As summarized in Table 2 , CIMTrisII appeared to detect CPE effectively compared with both CIMTris and mCIM.
This study has several limitations, in that the isolates tested were not comprehensive and balanced and all were from Asian countries. Because VIM-producing Acinetobacter and KPC-producing Pseudomonas species are rarely isolated in Asia, we were unable to test these important carbapenemase producers. Further testing of CIMTrisII with a more diverse group of Gram-negative pathogens is needed.
In conclusion, CIMTrisII is a useful method in the detection of carbapenemase activity in Gram-negative pathogens.
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